1. Introduction {#sec0005}
===============

Cognitive decline is a major hallmark of aging, and is exacerbated in individuals suffering from neurodegenerative disease. The mechanisms of brain aging are complex and include alterations in connectivity, increased inflammation, decreased neurogenesis, damage by free radicals, and dysregulation of gene expression networks \[[@ref001]\]. A number of signaling pathways have been implicated in maintaining normal cognitive function in the adult, including insulin/insulin-like growth factor (IGF) signaling. FOXO factors, known as DAF-16 in worms, are the key transcription factors downstream of insulin/IGF/AKT signaling ([Fig. 1](#nha-4-nha160009-g001){ref-type="fig"}). FOXOs are expressed broadly across several tissue types, including the brain, and are critical effectors of cellular homeostasis, metabolism, and the stress response. Work first performed in invertebrates demonstrated that FOXOs regulate organismal longevity, and increased FOXO activity can extend lifespan in various species \[[@ref002]\]. Recent studies focused on the nervous system have implicated FOXOs in cognitive performance, regeneration, and neurodegenerative disease. In this review, we discuss the contribution of the FOXO family of transcription factors to neuronal function in invertebrates and mammals. We first examine the evidence implicating FOXO factors in learning and memory across species. We then discuss the known roles of these factors in regeneration of the nervous system. Finally, we consider the evidence implicating FOXOs in the response to stress, neurodegeneration, and normal brain aging.

![The insulin/IGF signaling pathway. FOXO transcription factors are inhibited by insulin/IGF signaling. In the absence of insulin/IGF binding, FOXOs regulate a number of cellular processes (blue), which in turn affect tissue homeostasis and organismal longevity. Inset shows the orthologous pathway in *C. elegans*.](nha-4-nha160009-g001){#nha-4-nha160009-g001}

2. The FOXO family of transcription factors {#sec0010}
===========================================

FOXO transcription factors function downstream of insulin/IGF signaling and play a conserved role in longevity and cellular homeostasis. FOXOs are members of the Forkhead family of transcription factors, which are distinguished by a conserved winged helix DNA binding domain known as the 'Forkhead box' \[[@ref003]\]. *C. elegans* and *Drosophila* each have one FOXO gene, called DAF-16 and dFOXO, respectively. Mammals have four different FOXO isoforms (FOXO1, 3, 4 and 6). When activated, FOXOs function as pioneer transcription factors and can remodel compacted chromatin, with or without the help of ATP-dependent chromatin remodelers \[[@ref004]\]. FOXOs bind the consensus sequence TGTTTAC and primarily function as transcriptional activators, though repression has also been observed \[[@ref006]\].

FOXOs are negatively regulated by insulin/IGF and other growth factor signals. In *C. elegans*, there is only one insulin/IGF receptor, known as DAF-2. Growth factor signaling activates the phosphoinositide 3-kinase (PI3K)-AKT pathway, and FOXOs possess three conserved AKT-dependent phosphorylation sites \[[@ref009]\]. Phosphorylation at these sites inhibits FOXO activity by sequestering FOXO protein in the cytoplasm. Under conditions of low insulin or growth factors, FOXOs are unphosphorylated at the AKT-dependent phospho-sites, and are able to translocate into the nucleus and activate target genes. The FOXO6 isoform is an exception to this rule, as it does not shuttle between the nucleus and the cytoplasm in response to AKT, and is constitutively nuclear \[[@ref011]\]. In addition to the insulin/IGF/AKT signaling axis, FOXOs receive inputs from a number of other factors and signaling pathways, depending on environmental conditions. For example, FOXOs are phosphorylated by AMPK in response to alterations in nutrient signaling \[[@ref013]\], MST-1 and JNK under conditions of oxidative stress \[[@ref014]\], and SGK under conditions that promote survival and cell cycle progression \[[@ref017]\]. Additional covalent modifications to FOXO include methylation by SET9 and PRMT1, acetylation by p300 and CREB-binding protein, and deacetylation by SIRT1 \[[@ref018]\]. The combination of these post-translational modifications has been proposed to function as a FOXO 'code', which directs context-specific gene expression programs \[[@ref023]\]. Indeed, many mammalian targets of FOXO are tissue-specific, underscoring the complexity of FOXO's contribution to cell and tissue homeostasis \[[@ref024]\].

3. Contribution to cognitive function {#sec0015}
=====================================

3.1. Invertebrate studies {#sec0020}
-------------------------

*C. elegans* has emerged as a powerful model in neuroscience due to its relative simplicity, invariant cell lineage, stereotyped neuronal wiring, and behavioral plasticity. Each hermaphrodite worm has exactly 302 neurons, and the connectivity of these cells is consistent between animals \[[@ref025]\]. Thus, each individual neuron can be identified based on its unique position, connectivity, and morphology. In addition, worms respond to environmental stimuli and learn to modify their behavior in response to the particular stimulus. Learning and memory paradigms have been developed in *C. elegans* to assess associative learning, non-associative learning (habituation) and developmental imprinting \[[@ref026]\]. The insulin signaling pathway has been implicated in associative learning, in which worms are able to learn and remember specific environmental cues, such as an odor, taste, or temperature. Behavioral studies, in combination with recently developed genomics approaches have revealed neuron-specific functions for DAF-16/FOXO in learning and memory.

Murakami et al. observed that the insulin/IGF-1 signaling pathway regulates associative learning using an isothermal tracking paradigm \[[@ref027]\] ([Fig. 2](#nha-4-nha160009-g002){ref-type="fig"}). In the isothermal tracking assay, animals learn to associate temperature with food, and performance in this assay decays with age. The authors found that *age-1* (PI3K) and *daf-2* mutants, which have increased DAF-16 activity, have a delayed age-associated decline in this assay. This delay is suppressed by *daf-16* mutation. Thus, in this case, insulin/IGF signaling through the DAF-2 receptor reduces associative learning, whereas DAF-16 enhances it. In contrast, insulin/IGF-1 signaling has been reported to augment a different form of associative learning known as salt chemotaxis learning. This method uses salt starvation conditioning, in which the worms learn to associate salt with the absence of food. Learned salt aversion in this assay required insulin/IGF-1 signaling, as *daf-2*, *age-1* (PI3K), and *akt-1* mutants retained the ability to chemotax towards salt in naïve conditions, but were unable to develop a salt aversion \[[@ref028]\]. Conversely, *daf-18/PTEN* mutant worms, which have enhanced PI3K/AKT signaling, had increased associative learning in this assay compared to wild type animals. Why does insulin/IGF-1 signaling impair behavioral plasticity in one context (isothermal tracking) and promote it in another (salt avoidance behavior)? Interestingly, evidence suggests that the difference may be in the effectors downstream of AKT in each case. Whereas DAF-16 enhanced associative learning in isothermal tracking experiments, in the salt chemotaxis context, *daf-16* mutation only partially suppressed the learning defect of *daf-2* mutants. This finding indicates that other factors function downstream of the insulin/IGF-1 signaling axis in the salt starvation context. These signaling differences may reflect differences in the neuronal subtype involved, as the two types of learning are mediated by distinct sets of neurons. Consistent with this notion, Tomioka et al. show that the insulin/IGF-1 signaling functions in a particular neuronal subtype (ASER neurons) in salt chemotaxis learning, whereas isothermal tracking is mediated primarily by AFD neurons \[[@ref028]\].

![FOXOs have been implicated in learning and memory in *C. elegans* and mice. (A) Summary of the evidence implicating DAF-16 in the regulation of learning and memory in *C. elegans*. (B) Schematic representation of the domains of the hippocampus that express different FOXO isoforms in the mouse. The upper panel depicts a side view of the rodent brain. A coronal section at the level of the hippocampus (dotted line in the side view) is shown in the center. The bottom image shows a zoomed-in schematic of the hippocampus, and indicates where the different mammalian FOXO isoforms are expressed.](nha-4-nha160009-g002){#nha-4-nha160009-g002}

DAF-16 has also been shown to regulate memory performance during *C. elegans* aging. Kauffman et al. developed a positive olfactory association assay to assess learning and memory with age in worms. In this assay, worms learn to associate food with a specific odorant (butanone), for which chemosensation is mediated by the AWC neurons \[[@ref031]\]. After the initial learning stages, worms are assessed for short-term (2 hours) and long-term memory (16 hours). Long-term olfactory memory is the first neuronal function to be lost with age and, similar to mammals, this type of memory is regulated by CREB. Olfactory learning, chemotaxis and motility decline later in life (after one week of adulthood). In early adulthood, *daf-2* mutants maintain short-term memory three times as long as wild type worms, and have enhanced long-term memory. Both functions are dependent on *daf-16*. However, with age, *daf-2* mutant worms do not have an extension of long-term memory compared to wild type worms, and therefore do not maintain all forms of memory performance despite their increased longevity. This finding is consistent with the observation that insulin/IGF-1 signaling acts in the intestine, and not the neurons, to regulate longevity \[[@ref032]\]. These studies raise the question of whether DAF-16 regulates a specific set of neuron-specific genes.

The identity of the neuronal DAF-16 targets remained elusive for a long time in part due to the challenge of performing tissue-specific gene expression profiling in *C. elegans*. Worms possess a tough outer cuticle that makes sample preparation difficult, and they cannot be manually dissected due to their small size. Only recently, Kaletsky et al. were able to define these neuronal-specific transcriptomes \[[@ref033]\]. The authors used fluorescence activated cell sorting to isolate GFP-positive neurons from wild type, *daf-2* mutants and *daf-2;daf-16* mutants, followed by RNA-seq and comparison to whole worm transcriptomes. Consistent with neural-specific functions of DAF-16 that are separate from its role in longevity, neuron-specific DAF-16-regulated genes are distinct from longevity DAF-16 targets. Whole worm targets are most enriched in metabolism genes, whereas neuron targets are most enriched in neuronal functions (GPCR, ion channels, kinesins, etc.). Notably, regulation of these genes may be in part indirect since many of the putative DAF-16-regulated neuronal genes did not contain DAF-16 binding element sequence motifs. Nevertheless, the genes identified using this method are likely to be functional regulators of learning and memory directly or indirectly downstream of DAF-16 since RNAi against 80% of the top targets resulted in associative memory deficits. Which of the neuronal targets are directly regulated by DAF-16 remains to be determined. In addition, in future studies, as technology allows, it will be interesting to examine the expression networks downstream of DAF-16 in different neuronal subtypes since DAF-16 appears to be more important for maintaining youthful programs of gene expression in some neurons than others.

Together, these studies demonstrate that DAF-16 regulates a neuron-specific program of target genes whose function is to maintain learning and memory in the adult. In worms, neuronal DAF-16 targets are distinct from those regulating longevity. Similarly, dFOXO, the *Drosophila* FOXO ortholog, functions in the fat body, and not the brain to regulate lifespan in the fly \[[@ref034]\].

3.2. Mammalian studies {#sec0025}
----------------------

The extensive evidence implicating the *C. elegans* FOXO ortholog in learning and memory raises the question of whether this function is conserved in other species. Moreover, insulin/IGF signaling has been strongly linked to cognition in mammals, and particular alleles of FOXO3 have been linked to enhanced cognitive function in humans with age \[[@ref035]\]. However, the underlying mechanism remains unknown. All four FOXO isoforms are expressed in the mammalian brain (though FOXO4 is expressed at much lower levels than the others) \[[@ref006]\]. Genetic mouse models have been generated for all FOXOs, and mice with complete knockout of *Foxo3*, *4*, and *6* are viable \[[@ref038]\], whereas complete knockout of *Foxo1* is embryonic lethal. Brain-targeted *Foxo1* knockout mice (using a Nestin-Cre driver) have also been generated to circumvent the lethality of the complete knockout \[[@ref041]\]. These mouse models have been used in several studies to investigate functions of FOXOs in the brain. However, thus far, studies investigating the contribution of mammalian FOXOs to learning and memory have been limited to FOXO6 \[[@ref038]\]. Although they haven't been investigated in learning and memory functions, both FOXO1 and FOXO3 have been implicated in regulating anxiety-like behaviors in adult mice \[[@ref041]\]. FOXO3 also functions in a reward center of the brain, known as the nucleus accumbens (ventral striatum), to modulate the behavioral response to cocaine \[[@ref042]\]. These studies suggest functions for FOXO factors in serotonergic signaling and reward circuitry in the brain, respectively.

FOXO6 is the main FOXO isoform that has been linked to cognitive function in the mouse \[[@ref038]\]. FOXO6 is strongly expressed in the CA1 and CA3 regions of the hippocampus, but not in the dentate gyrus ([Fig. 2](#nha-4-nha160009-g002){ref-type="fig"}). Functionally, FOXO6 is required to establish neuronal polarity, and regulates a gene expression program in that is essential for neuronal connectivity in the hippocampus \[[@ref043]\]. In the absence of FOXO6, associative learning in contextual fear conditioning and novel object recognition assays is normal, but mice are impaired in memory consolidation \[[@ref038]\]. Precisely how FOXO6's function relates to that of other FOXOs in the brain remains unknown. FOXO3 is enriched in all regions of the hippocampus (dentate gyrus, CA1, CA2 and CA3), and FOXO1 is expressed in the dentate gyrus and in ventral CA3 pyramidal neurons ([Fig. 2](#nha-4-nha160009-g002){ref-type="fig"}) \[[@ref036]\]. Thus, based on gene expression patterns, FOXOs may have both overlapping and separate roles in the hippocampus. Functionally, the contribution of each factor remains unknown. Similar to FOXO1, 3 and 4, FOXO6 is negatively regulated by insulin/IGF-1 signaling. However, unlike the other isoforms, FOXO6 does not shuttle between the nucleus and the cytoplasm \[[@ref011]\], suggesting some differences in how this isoform is regulated. In addition, all four isoforms are highly similar in their DNA binding domains, but diverge outside of this region. Thus, the different FOXOs may partner with different cofactors to regulate different gene expression programs in the hippocampus, which regulate diverse cellular processes in learning and memory. Future studies, including behavioral analysis, expression profiling, and electrophysiological approaches will be necessary to address this important question.

In addition, it will be important to test whether a function of FOXOs in mammals is to preserve neuronal function with age, similar to their role in *C. elegans*. During mammalian aging, the coordination and integration of neural activity are disrupted, resulting in reduced cognitive capacity \[[@ref001]\]. The underlying mechanisms, including the potential role of FOXO factors in cognitive aging, are likely to be complex. Intriguingly, expression profiling of the human brain during aging revealed dysregulation of synaptic genes with age \[[@ref044]\]. Whether these are the same genes that are regulated by FOXO6 in the mouse hippocampus is unknown, but it suggests the possibility that FOXO6 may maintain memory performance with age by coordinating synaptic stability. However, paradoxically, insulin/IGF signaling is generally considered protective in the aging brain \[[@ref045]\]. Insulin/IGF signaling supports neuronal survival, synaptogenesis, neurotransmission, neurogenesis, and memory retention. Conversely, knockout of the IGF-1 receptor or the *Irs2* signaling molecule are protective in Alzheimer's models \[[@ref046]\]. Altogether, these findings suggest that cognitive performance depends on optimal levels of insulin/IGF signaling and FOXO activation in the brain. Additional studies will be required to fully understand how this balance is achieved, and define the role of the different FOXO family members in adult cognition.

4. Axon growth and regeneration {#sec0030}
===============================

4.1. Lessons from invertebrates {#sec0035}
-------------------------------

Early studies employing electron microscopy in *C. elegans* suggested that neurons remain structurally intact in nematodes with age, despite deterioration of the surrounding tissue \[[@ref049]\]. However, worms display reduced motility and associative learning with age \[[@ref027]\], indicating that neurons are functionally impaired in aged animals. Indeed, more recent studies using fluorescent reporter strains have revealed defects in several neuronal subtypes with age, including mechanosensory neurons, GABAergic motor neurons, and cholinergic neurons. Here we consider the evidence suggesting that in different neuronal contexts, neurite outgrowth, structural maintenance, and regeneration are all regulated by DAF-16 during aging.

*C. elegans* aging is accompanied by several alterations to the nervous system, including increased dendrite branching, axonal defasciculation, neuronal blebbing, ectopic axonal outgrowth, and reduced regenerative ability. These features of neuronal aging are all regulated by DAF-16 and, interestingly, can be uncoupled from DAF-16's role in organismal aging. For example, mechanosensory and GABAeric neurons in aging worms develop ectopic branches, correlating with a decline in mobility and responsiveness to touch \[[@ref050]\]. In addition to regulation by DAF-16, branching is also controlled by MAPK signaling involving the JNK-1 and JKK-1 kinases (but not other MAPK members). *jnk-1* and *jkk-1* mutants have an accelerated branching of mechanosensory and GABAergic neurons, and have corresponding locomotory defects. Tissue-specific expression experiments showed that JNK-1 and DAF-16 function cell autonomously. However, unlike in the context of organismal longevity where JNK-1 acts directly upstream of DAF-16, in neurons these factors function independently to regulate branching. Interestingly, these experiments also uncoupled DAF-16's role in neurite branching from the rate of organismal aging since reducing *daf-2* in all tissues but neurons extended lifespan, but did not promote more youthful branching morphologies \[[@ref016]\].

DAF-16 also maintains the integrity of touch receptor neurons in *C. elegans*. During aging, these neurons develop blebs and aberrant branches, including ectopic axonal outgrowth from the soma \[[@ref050]\]. Deterioration of synaptic integrity has also been observed with age in worms, which is reminiscent of what has been observed in humans \[[@ref001]\]. *daf-2* mutants are delayed in the onset of these defects, and *daf-16* is required for this phenotype. In contrast to *daf-2* worms, *eat-2* mutants do not exhibit delayed neuronal aging, indicating that not all long-lived mutants are protected from neuronal alterations with age. Therefore, simply delaying aging is not sufficient for neuroprotection, again suggesting that neuronal aging is regulated cell autonomously. Notably, some neurons in *C. elegans* do not have age-associated morphological abnormalities (e.g. inhibitory GABAergic motor neurons, nerve ring interneurons) \[[@ref052]\]. What are the mechanisms that specifically act in some neuronal subtypes to maintain morphology and function with age? The mechanism has yet to be fully elucidated but two lines of evidence indicate that mitochondria may play a role. First, mitochondria are often associated with neurite branch sites \[[@ref052]\]. And second, *clk-1* mutants, which exhibit reduced respiration and extended lifespan, also have delayed neurite branching \[[@ref050]\]. The precise effect that mitochondria, or the electron transport chain, have on neurite branching is not clear, but manipulating ROS levels using paraquat does not alter neurite branching, suggesting that dysfunctional branching is not caused by oxidative stress \[[@ref050]\]. Future work will be required to define the precise mechanism downstream of DAF-16 in this process and whether regulation of mitochondrial function isinvolved.

*C. elegans* have the ability to regenerate neurons in adulthood, and this capacity is reduced with age. Adult neurons can be severed using laser axotomy, which allows for accurate and reproducible cutting of single neurons *in vivo*, followed by a stereotyped regenerative response \[[@ref053]\]. This approach has been proposed as a model system to identify the molecular regulators of regeneration, and the mechanisms underlying its decline during aging \[[@ref054]\]. Using this approach, Byrne et al. characterized the decay in GABA motor neuron regeneration with age \[[@ref056]\]. Most young adult (day 1) animals were able to regenerate, but by day 5 of adulthood, only about one quarter of severed axons could initiate regeneration, and those that could initiate failed to fully extend toward their targets. The age-related decline in regenerative capacity was delayed in *daf-2* mutants, and this response required DAF-16. DAF-16 acts cell autonomously in neurons to regulate regeneration, independent of its functions in longevity. Moreover, other manipulations that extend lifespan (e.g. dietary restriction) do not improve regeneration, supporting the notion that improving regeneration is not simply a consequence of extending lifespan or healthspan. This result is somewhat surprising since DAF-16 has been found to be required for lifespan extension in response to some forms of dietary restriction. The mechanistic underpinnings responsible for this difference remains unknown, but one possibility is that it depends on the type of dietary restriction used. In the Byrne et al. study, *eat-2* mutants were used to induce dietary restriction. However, DAF-16 is not completely necessary for *eat-2*-induced longevity \[[@ref057]\]. Perhaps other methods of dietary restriction would enhance regeneration. Nevertheless, this study suggests that DAF-16 promotes neuronal regeneration via a cell-intrinsic mechanism independent of its role in longevity, as expression of DAF-16 specifically in neurons rescued the age-associated deterioration of motor neuron regeneration \[[@ref056]\].

DAF-16 also regulates development of the nervous system, and this function may be conserved in mammals. During development, DAF-16 promotes neurite outgrowth in interneurons that modulate locomotory behavior and thermotaxis (AIY neurons) \[[@ref059]\]. The morphology of these neurons is highly stereotyped during development, and disruptions in AIY growth can be easily visualized using fluorescence microscopy. *daf-16* mutants are defective in AIY neurite outgrowth and, interestingly, this function of DAF-16 is performed by one particular DAF-16 isoform, DAF-16B. Previous studies had implicated the DAF-16A, D and F isoforms as the variants that regulate longevity \[[@ref060]\], suggesting that the regulation of aging and neuronal patterning by DAF-16 can be uncoupled. Notably, the N-terminal half of the DNA binding domain is encoded by different exons in DAF-16A and B. Thus, differences in motif binding preferences and therefore target gene regulation may drive neuron-specific versus longevity functions of DAF-16. However, this has yet to be explored. DAF-16A and B are also regulated by distinct promoters \[[@ref061]\], which is also likely to contribute to their distinct functions. Importantly, Christensen et al. extend their findings to a mammalian system and find that FOXO is necessary for axon outgrowth in rat primary cerebellar granule neurons \[[@ref059]\]. Simultaneous knockdown of FOXO1, 3, and 6 reduced axon length in these cells, and this phenotype could be rescued by expression of FOXO6. FOXO1 and FOXO3 were not tested, so the contribution of these isoforms to axon growth in mammals remains unclear. Nevertheless, these findings are consistent with the observation that FOXO6 knockout mice have decreased dendritic spine density in hippocampal neurons *in vivo* \[[@ref038]\], and that FOXO6 regulates neuronal polarity.

4.2. Axon regeneration in mammalian systems {#sec0040}
-------------------------------------------

Unlike the central nervous system, the mammalian peripheral nervous system (PNS) possesses the ability to regenerate. Common types of PNS injury are lacerations, contusions and avulsion (detachment) type injuries. However, the rate of regeneration is slow (1--3 mm per day), and functional recovery is often incomplete. A number of genes associated with regeneration in mammals have been identified. These factors include neurotrophic factors and structural proteins that orchestrate the repair and regrowth of nerves. Induction of the regeneration program peaks at one week post injury, then declines over the course of 2-3 months \[[@ref062]\]. Regeneration also depends on Schwann cells, which provide growth support to the regenerating axons. Similar to *C. elegans*, regeneration of peripheral nerves also declines with age in mammals \[[@ref063]\], and the PI3K-AKT signaling pathway has been implicated in the process of regeneration \[[@ref062]\]. However, in contrast to what has been observed in the nematode, IGF-1 can stimulate regeneration of mammalian axons in response to injury \[[@ref065]\]. Consistent with this observation, FOXO3 levels are reduced in neurons and glia within 48 hours of spinal cord injury, and gradually recover over the course of four weeks \[[@ref066]\]. This trajectory is anti-correlated with PCNA levels and expression of GAP-43, a presynaptic membrane protein that guides axon regeneration. The relative contribution of FOXO3 in neurons versus glia is not known. In a model of acute spinal cord contusion, FOXO3 was primarily downregulated in astrocytes, which are induced to proliferate in response to injury \[[@ref067]\]. While these studies do not address the functional role of FOXO3 in astrocytes upon injury, these finding suggest that FOXO3 functions in some way to restrain scar formation after spinal cord injury.

5. FOXOs and neurogenesis {#sec0045}
=========================

In mammalian embryonic and postnatal development, neural stem cells (NSCs) give rise to neurons and glia that shape the basic architecture of the central nervous system. The adult brain then retains some of its capacity to generate new functional neurons by preserving a small population of NSCs \[[@ref068]\]. In the healthy brain, adult neurogenesis is restricted to the two neurogenic niches: the subventricular zone (SVZ) lining the lateral ventricles and the dentate gyrus (DG) region of the hippocampus. In these niche microenvironments, adult NSCs reside mostly in a quiescent state, but maintain their multipotency and ability to proliferate and self-renew \[[@ref072]\]. Through integration of new neurons into the hippocampal and olfactory circuitry, adult neurogenesis allows mammals greater cognitive plasticity and contextual learning abilities \[[@ref073]\]. However, adult neurogenesis also declines with age, and the subsequent failure to adequately replenish the brain with functional neurons may contribute to the cognitive decline of the aging brain \[[@ref074]\]. In mammals, FOXOs are key regulators of stem cells, including NSCs. Complete knockout of *Foxo3* or brain-specific triple knockout of *Foxo1, 3, and 4* results in a depletion of the NSC pool \[[@ref077]\]. In both cases, ablation of FOXO function significantly increases brain size, and induces precocious NSC proliferation during development and early adulthood. This initial surge in NSC proliferation in the absence of FOXOs is followed by a progressive decline in self-renewal potential, resulting in a premature depletion of the NSCreserve.

Genome-wide microarray analysis comparing *Foxo3* knockout and wild type NSCs revealed that FOXO3 regulates expression of genes involved in quiescence, oxidative stress resistance, glucose metabolism and transport, and early neurogenesis \[[@ref078]\]. Altogether, this program is critical for maintaining NSC functionality in the brain, and possibly during aging. For example, excess reactive oxygen species (ROS) contributes to functional decline in stem cells, and high levels of ROS can prematurely activate stem cells and deplete the reserve \[[@ref079]\]. Extensive evidence has demonstrated that FOXOs protect various cell types, including stem cells, from ROS \[[@ref080]\]. However, treatment of FOXO-null NSCs with N-acetyl-cysteine to restore normal ROS levels only partially rescues NSC self-renewal \[[@ref077]\], indicating that additional mechanisms are at play downstream of FOXOs in these cells. Interestingly, embryonic stem cell-derived neural progenitor cultures in a BMP4-induced quiescent state show enrichment for expression of FOXO-regulated genes \[[@ref083]\], suggesting a 'quiescence program' downstream of FOXOs. In contrast, FOXO-regulated genes in the NSCs do not overlap extensively with those in hematopoietic stem cells, indicating a neural-specific FOXO transcriptional network that is not shared by other stem cells \[[@ref077]\].

ChIP-seq analysis of the direct targets of FOXO3 in adult NSCs has more precisely defined the mechanism by which FOXOs regulate NSCs \[[@ref008]\]. FOXO3 binds over 2,000 direct targets in NSCs, and many of these targets are neural-specific (not bound by FOXOs in other mouse tissues) \[[@ref024]\]. Intriguingly, neural-specific targets of FOXO include genes in the Alzheimer's disease presenilin pathway, though the functional relevance of these targets downstream of FOXOs has not been assessed. As expected, many of the target genes bound by FOXO3 in NSCs were also transcriptionally regulated by this factor based on transcriptome analysis \[[@ref008]\]. However, a subset of FOXO3-bound genes were not observed to be transcriptionally regulated. The absence of regulation in these assays remains unknown, but may be due to redundancy among FOXO family members, or that these targets are only regulated under particular conditions. ChIP-seq analysis in NSCs also revealed a genome-wide network of targets shared with the pro-neural transcription factor ASCL1. FOXO3 and ASCL1 are co-enriched at enhancers of Notch and Wnt signaling pathway genes known to regulate the balance between stemness and cell fate commitment \[[@ref008]\]. Furthermore, FOXO3 inhibits ASCL1-dependent neurogenesis in progenitors as well as ASCL1's ability to directly reprogram fibroblasts into neurons. Altogether, these lines of evidence point to a role for FOXO in adult neurogenesis through maintenance of the NSC reserve.

In contrast to mammals, adult neurogenesis is absent in *Drosophila*, because no reserve of NSCs remains post-development. Interestingly, the single fly FOXO ortholog, dFOXO, plays a critical role in eliminating the neuroblasts in the young adult fly. As a result of reduced insulin-PI3K-AKT signaling, dFOXO translocates into the nucleus of the neuroblasts and activates caspase-dependent apoptosis \[[@ref085]\]. Absence of dFOXO and Reaper pro-apoptosis genes leads to long-term survival of the neuroblasts and prolonged neurogenesis in the adult mushroom body (center for learning and memory in *Drosophila*). Siegrist et al. demonstrated that these apoptosis-deficient neuroblasts have impaired growth, suggesting that dFOXO-mediated elimination of neuroblasts is beneficial to the fly. Therefore, while FOXOs regulate adult neural stem and progenitor cells in *Drosophila* and mice with different outcomes, their function as critical regulators of cellular homeostasis may optimize overall cognitive healthspan across species.

6. Neuronal stress and neurodegenerative diseases {#sec0050}
=================================================

Oxidative stress results from the overproduction of reactive oxygen species (ROS). ROS have been proposed to cause aging, and are generally considered to be detrimental to brain function, particularly in neurons. However, ROS also function as cellular messengers essential for cellular homeostasis. High levels of ROS generated in response to ischemic stroke or in neurodegeneration are a major cause of neuronal death. Across many cell types, FOXOs are activated in response to oxidative stress \[[@ref021]\]. Once activated, FOXOs transcriptionally activate genes such as catalase and MnSOD, which in turn reduce intracellular ROS levels. Counterintuitively, insulin/IGF signaling protects against oxidative stress in the brain, including under conditions of extremely high oxidative stress, such as ischemic stroke. Insulin/IGF signaling is protective in the brain in part by blocking FOXO-induced neuronal death. Trophic deprivation and oxidative stress strongly activate FOXO in neurons. Under these conditions, FOXO induces pro-apoptotic genes such as BIM \[[@ref087]\].

Activation of FOXO in conditions of oxidative stress involves several signaling molecules. Mammalian sterile 20-like kinase 1 (MST1) is a key regulator of oxidative stress-induced death in neurons and glia \[[@ref014]\]. In postnatal rat granule neurons and cortical astrocytes, MST1 is activated by oxidative stress and phosphorylates FOXO3 within its forkhead domain \[[@ref014]\]. Phosphorylation at this site induces FOXO3 translocation to the nucleus and induction of cell death. Interestingly, this mechanism of FOXO activation is conserved across species, as *C. elegans* DAF-16 is phosphorylated by the worm ortholog of MST1 (CST-1) at a conserved serine residue. CST-1 overexpression extends lifespan in a *daf-16* dependent manner. Davila et al. found that full activation of FOXO3 in response to oxidative stress in neurons involves inhibition of AKT, followed by activation of FOXO3 by JNK2 \[[@ref089]\]. This mechanism appears to be specific to neurons, since p38/MAPK was not observed to inhibit AKT in response to H~2~O~2~ in astrocytes \[[@ref090]\]. Consistent with these findings, FOXOs are strongly activated in *in vivo* rodent models of ischemic stroke, and may contribute to cell death in the infarct region \[[@ref091]\]. During normal aging, neuronal death is limited in the brain, suggesting that FOXO-induced neuronal death is not a major contributor to brain aging. However, in the context of neurodegenerative disease or in response to injury, oxidative stress can be an important contributor to neuronal death.

In addition to oxidative stress, FOXOs have emerged as important regulators of proteotoxic stress. Proteotoxicity is a major feature of neurodegenerative disease and occurs when cells accumulate damaged, misfolded, or aggregated proteins. A number of studies performed in *C. elegans* have shown that DAF-16 (or at least *daf-2* mutation) can promote clearance of A*β* \[[@ref093]\] and polyglutamine \[[@ref094]\], and alleviates the effects of mutant SOD1 \[[@ref097]\]. Mechanistically, FOXOs promote autophagy, proteasome activity, and chaperone activity, and these activities are broadly conserved across species \[[@ref099]\]. Nevertheless, investigation of the role FOXO in neurodegeneration or protein quality control in the mammalian brain has been limited so far. Most of the evidence associating FOXOs with proteostasis is from non-neuronal systems, although emerging evidence suggests FOXOs function similarly in neuronal cell types as well \[[@ref100]\]. Moreover, studies directly linking FOXO with reduced proteotoxiciy in the diseased setting have been limited, although FOXO has been shown to clear *α*-synuclein and defective mitochondria indopaminergic neurons, which are affected in Parkinson's disease \[[@ref102]\]. Together with evidence suggesting that reduced insulin/IGF signaling is protective in Alzheimer's disease \[[@ref001]\], these findings suggest that FOXOs may have a broader role in protecting the brain from degeneration. Future studies will be required to address this important question.

7. FOXO in the brain: An integrated model {#sec0055}
=========================================

Studies performed in worms, flies and mice have implicated FOXO transcription factors in the regulation of NSCs, learning and memory, axon regeneration, and the neuronal stress response ([Fig. 3](#nha-4-nha160009-g003){ref-type="fig"}). At first glance, these functions appear disparate and mechanistically disconnected. However, it must be considered that altered environmental conditions that affect cognitive performance such as aging, neurodegenerative disease, or metabolic syndromes (i.e. diabetes) would have global effects on FOXO activity. Thus, an integrated understanding of FOXO's many roles in the nervous system is necessary to fully grasp how the brain becomes dysfunctional in each of these circumstances. The key to building an integrated model of FOXO's role in the brain is in understanding the inputs that modulate its function and the outputs it produces in different contexts.

![The neuronal functions of FOXO transcription factors in *C. elegans* and mammals.](nha-4-nha160009-g003){#nha-4-nha160009-g003}

Many unanswered questions remain regarding the inputs regulating FOXOs in the brain. FOXOs receive inputs from the environment, including circulating and locally produced growth factors, metabolic cues, and oxidative stress signals. Do FOXOs elicit cell-type specific responses to these different inputs in different neuronal subtypes and regions of the brain? Do these inputs change during aging or in neurodegenerative disease? Moreover, how are multiple signals incorporated to direct context and condition-specific programs of gene expression? It remains possible that there may be additional upstream regulators of FOXOs in addition to the well-characterized PI3K-AKT signaling, MST, and JNK-mediated redox signaling. Identification of alternative regulators of FOXOs is likely to explain some of their cell type-specific actions. Another unresolved question regarding the inputs regulating FOXOs is the extent to which FOXO levels or activity are affected by interventions that extend lifespan. In the case of dietary restriction, DAF-16/FOXOs modulates the response in some, but not all, species, and the requirement also depends on the method of dietary restriction used \[[@ref057]\]. Given the extensive evidence that FOXOs promote longevity, it is possible that they are activated in response to pharmacological interventions that delay aging, such as rapamycin, metformin, or 17-*α*-estradiol, but this has yet to be fully investigated. Emerging evidence indicates that in addition to delayed organismal aging, interventions that extend lifespan also enhance cognitive health during aging. For example, lifelong treatment with rapamycin, an mTORC1 inhibitor, improves the age-dependent decline in spatial memory in mice \[[@ref106]\]. In addition, mTORC1 activation induces neurogenesis and terminal differentiation in the adult mouse SVZ, suggesting a potential role of mTORC1 in the exhaustion of the NSC pool with age \[[@ref107]\]. Metformin, which activates AMPK, has been shown to affect multiple stages of neurogenesis (proliferation, self-renewal, and differentiation) \[[@ref108]\]. Whether FOXOs mediate these effects is unknown, but metformin can activate FOXO3 in stem-like glioma cells \[[@ref109]\], suggesting a possible role for these factors in response to this drug. In summary, the extent to which FOXOs are involved in mediating the effects of longevity-promoting interventions and other inputs in the brain is likely to be an exciting area of futureresearch.

Downstream of these inputs, how do FOXOs regulate a diverse range of processes? The answer is not fully understood, but emerging genomic evidence suggests that specific functions of FOXO factors rely on integration with other transcription factor networks. FOXOs interact with a number of transcription factors in different cell types and contexts (e.g. ETS, bHLH factors, b-catenin) \[[@ref008]\]. The functional diversity of the transcription factors that are associated with FOXOs may confer functional versatility, depending on the needs of the cell. For example, FOXO-associated factors can specifically direct a particular cellular response, such as autophagy or oxidative stress \[[@ref099]\]. In other contexts, FOXOs contribute to cell fate decisions by sharing common targets genome-wide with cell type-specific transcriptional regulators \[[@ref008]\]. These interactions with co-regulators can be synergistic or antagonistic. Recent work identified a number of new candidate co-regulators that may explain other aspects of FOXO's functions \[[@ref024]\]. The precise interactions between FOXOs and other signaling pathways in the brain remain to be addressed. Given FOXO's role as one of the major nodes in the response to environmental cues, understanding how FOXOs are regulated in different contexts is likely to be key for understanding neuronal homeostasis in the healthy and diseasedbrain.
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